In addition, monitoring SPRR1A levels in the margin could be a useful tool in assessing the risk of micrometastasis or early premalignant lesions, which would allow a more precise mapping of the extent of the tumour lesion when planning surgical circumstances and delineating resection boundaries [17,18,20]. The gene discussed is SPRR1A; the disease is neoplasm.